Survivors to Moderate New Social Network

www.CancerConnect.com Seeks Active Cancer Patients and Survivors to help Moderate a new on line network where Patients can talk to other Patients. CancerConnect provides modest financial remuneration or will make a donation to a organization of the moderators choosing.

For over 10 years, CancerConsultants.com has been a leading online destination for cancer patients and caregivers - providing information, resources, inspiration, and hope. Now, our users have asked for more and we’ve responded - with the launch of our new Patient network, CancerConnect.
CancerConnect is essentially a "Facebook" for cancer patients with a few exceptions.

Unlike Facebook, it is moderated by individuals that have and understand cancer and discussion occur in safe and secure environment. www.CancerConnect.com is a network - designed by cancer patients for cancer patients - it provides a place to connect and share ideas and support. It is a vibrant community of people who are navigating cancer; it is a supportive environment; it is a resource; and it is so much more. CancerConnect is the thread that links each of us, reminding us that it is a small world after all.

In order to provide the optimal experience for all members, CancerConnect will need moderators. That’s where you come in. Sure, doctors, nurses, pharmacists, and researchers might know the facts of cancer – but no one understands the experience better than someone who has been there. Simply put, patients want to talk to others that have “been there” Don’t you wish that someone had been there for you to guide you through the process? Now is your chance to give back and be that pillar of support and wealth of experience and information for others.

We are looking for individuals that either have, or have had cancer to serve as moderators and/or facilitators. The role of the moderator is to monitor activity in the forums, facilitate topics and discussions and ensure a safe, respectful experience for all users.

We know what it means to be passionate about sharing knowledge and helping others, and we are excited to launch this innovative community - with your help. If you think you might like to learn more about becoming a moderator please contact chweaver@cancerconsultants.com.

Blog Category: 

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap